Downfield magnetic resonance signals serve as endogenous imaging biomarkers of nucleotide metabolism in glioma

Posted on
downfield-magnetic-resonance-signals-serve-as-endogenous-imaging-biomarkers-of-nucleotide-metabolism-in-glioma
Downfield magnetic resonance signals serve as endogenous imaging biomarkers of nucleotide metabolism in glioma

References

  1. Roca A. et al. Effect of intrapartum azithromycin vs placebo on neonatal sepsis and death: a randomized clinical trial. JAMA 329, 716–724 (2023).

  2. Schaff, L. R. & Mellinghoff, I. K. Glioblastoma and other primary brain malignancies in adults. JAMA 329, 574–587 (2023).

  3. Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231–1251 (2021).

    Google Scholar 

  4. Kurokawa, R. et al. Major changes in 2021 World Health Organization classification of central nervous system tumors. RadioGraphics 42, 1474–1493 (2022).

    Google Scholar 

  5. Mori, S., Eleff, S. M., Pilatus, U., Mori, N. & van Zijl, P. C. M. Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in Situ. Magn. Reson. Med. 40, 36–42 (2005).

    Google Scholar 

  6. Fichtner, N. D., Henning, A., Zoelch, N., Boesch, C. & Kreis, R. Elucidation of the downfield spectrum of human brain at 7 T using multiple inversion recovery delays and echo times. Magn. Reson. Med. 78, 11–19 (2016).

    Google Scholar 

  7. Borbath, T., Murali-Manohar, S., Wright, A. M. & Henning, A. In vivo characterization of downfield peaks at 9.4 T: T2 relaxation times, quantification, pH estimation, and assignments. Magn. Reson. Med. 85, 587–600 (2020).

    Google Scholar 

  8. Li, Y. et al. Leveraging adenosine triphosphate for cancer theranostics. Theranostics 15, 4708–4733 (2025).

    Google Scholar 

  9. Kreis, R., Zwygart, K., Boesch, C. & Nuoffer, J. M. Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy. Magn. Reson. Med. 62, 11–16 (2009).

    Google Scholar 

  10. Dziadosz, M., Bogner, W. & Kreis, R. Non-water-excitation MR spectroscopy techniques to explore exchanging protons in human brain at 3 T. Magn. Reson. Med. 84, 2352–2363 (2020).

    Google Scholar 

  11. Fichtner, N. D. et al. In vivo characterization of the downfield part of 1H MR spectra of human brain at 9.4T: magnetization exchange with water and relation to conventionally determined metabolite content. Magn. Reson. Med. 79, 2863–2873 (2017).

  12. Gonçalves, S. I., Simões, R. V. & Shemesh, N. Short TE downfield magnetic resonance spectroscopy in a mouse model of brain glioma. Magn. Reson. Med. 88, 524–536 (2022).

    Google Scholar 

  13. Povazan M., Schar M., Gillen J. & Barker P. B. Magnetic resonance spectroscopic imaging of downfield proton resonances in the human brain at 3 T. Magn. Reson. Med. 87, 1661–1672 (2022).

  14. Özdemir, I. et al. Downfield Proton MRSI with whole-brain coverage at 3T. Magn. Reson. Med. 90, 814–822 (2023).

  15. Gonçalves, S. I., Ligneul, C. & Shemesh, N. Short echo time relaxation-enhanced MR spectroscopy reveals broad downfield resonances. Magn. Reson. Med. 82, 1266–1277 (2019).

    Google Scholar 

  16. Zöllner H. J. et al. Comparison of different linear-combination modeling algorithms for short-TE proton spectra. NMR Biomed. 34, e4482 (2021).

  17. Feng, S. & Liu, Y. Metabolomics of glioma. in Cancer Metabolomics (eds. Prabhu, P. N. & Gupta, S. K.) 261–276 (Springer International Publishing, 2021).

  18. Mukherjee, A. G. et al. Recent advances in understanding brain cancer metabolomics: a review. Med. Oncol. 40, 220 (2023).

    Google Scholar 

  19. Gaca-Tabaszewska, M., Bogusiewicz, J. & Bojko, B. Metabolomic and lipidomic profiling of gliomas—a new direction in personalized therapies. Cancers 14, 5041 (2022).

  20. Miller, J. J. et al. Isocitrate dehydrogenase (IDH) mutant gliomas: a society for neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncol. 25, 4–25 (2023).

    Google Scholar 

  21. Xiao, X. et al. Tumor size as a significant prognostic factor in T1 gastric cancer: a surveillance, epidemiology, and end results (SEER) database analysis. BMC Gastroenterol. 23, 121 (2023).

    Google Scholar 

  22. Kazda, T. et al. Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging. NeuroImage: Clin. 11, 316–321 (2016).

    Google Scholar 

  23. MacMillan, E. L. et al. Magnetization exchange with water andT1relaxation of the downfield resonances in human brain spectra at 3.0 T. Magn. Reson. Med. 65, 1239–1246 (2011).

    Google Scholar 

  24. Özdemir, I. et al. Downfield proton MRSI at 3 Tesla: a pilot study in human brain tumors. Cancers 15, 3336 (2023).

  25. Prisciandaro, J. J., Zollner, H. J., Murali-Manohar, S., Oeltzschner, G. & Edden, R. A. E. More than one-half of the variance in in vivo proton MR spectroscopy metabolite estimates is common to all metabolites. NMR Biomed. 36, e4907 (2023).

    Google Scholar 

  26. Vejdani Afkham, B. & Alonso-Ortiz, E. On the impact of B0 shimming algorithms on single-voxel MR spectroscopy. Magn. Reson. Med. 93, 42–50 (2025).

    Google Scholar 

  27. Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62–76 (2020).

    Google Scholar 

  28. Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V. & Fendt, S. M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev. Cell 56, 1363–1393 (2021).

    Google Scholar 

  29. Traut, T. W. Physiological concentrations of purines and pyrimidines. Mol. Cell Biochem. 140, 1–22 (1994).

    Google Scholar 

  30. Mullen, N. J. & Singh, P. K. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat. Rev. Cancer 23, 275–294 (2023).

    Google Scholar 

  31. Wishart, D. S. Metabolomics for investigating physiological and pathophysiological processes. Physiol. Rev. 99, 1819–1875 (2019).

    Google Scholar 

  32. De Graaf, R. A. In Vivo NMR Spectroscopy: Principles and Techniques (John Wiley & Sons, 2018).

  33. Behar, K. L., Rothman, D. L., Spencer, D. D. & Petroff, O. A. C. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn. Reson. Med. 32, 294–302 (2005).

    Google Scholar 

  34. Howe, F. A. et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 49, 223–232 (2003).

    Google Scholar 

  35. Dienel, G. A. Metabolomic assays of postmortem brain extracts: pitfalls in extrapolation of concentrations of glucose and amino acids to metabolic dysregulation in vivo in neurological diseases. Neurochem. Res. 44, 2239–2260 (2018).

    Google Scholar 

  36. Henning, A. et al. Downfield spectra at ultrahigh field. Proc. Intl. Soc. Mag. Reson. Med. 16, 610 (2008).

  37. Giuliani, P. et al. Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells. J. Neurochem. 141, 208–221 (2017).

    Google Scholar 

  38. Lee D. C. et al. Amino acid and glucose fermentation maintain ATP content in mouse and human malignant glioma cells. ASN Neuro 16, 1–25 (2024).

  39. Wu, C. Y.-J. et al. Tumor-associated microglia secrete extracellular ATP to support glioblastoma progression. Cancer Res. 84, 4017–4030 (2024).

    Google Scholar 

  40. Hoefemann, M., Döring, A., Fichtner, N. D. & Kreis, R. Combining chemical exchange saturation transfer and1H magnetic resonance spectroscopy for simultaneous determination of metabolite concentrations and effects of magnetization exchange. Magn. Reson. Med. 85, 1766–1782 (2020).

    Google Scholar 

  41. Fichtner, N. D. et al. In vivo characterization of the downfield part of 1H MR spectra of human brain at 9.4 T: Magnetization exchange with water and relation to conventionally determined metabolite content. Magn. Reson. Med. 79, 2863–2873 (2017).

    Google Scholar 

  42. Özdemir İ, Etyemez S., Barker P. B. Amide mapping in the human brain using downfield MRSI at 3 T and 7 T. Magn. Reson. Med. 93, 497–508 (2025).

  43. Schanda, P., Van Melckebeke, H. & Brutscher, B. Speeding up three-dimensional protein NMR experiments to a few minutes. J. Am. Chem. Soc. 128, 9042–9043 (2006).

    Google Scholar 

  44. Shemesh, N., Dumez, J. N. & Frydman, L. Longitudinal relaxation enhancement in 1h nmr spectroscopy of tissue metabolites via spectrally selective excitation. Chem. – A Eur. J. 19, 13002–13008 (2013).

    Google Scholar 

  45. Schanda, P. Fast-pulsing longitudinal relaxation optimized techniques: enriching the toolbox of fast biomolecular NMR spectroscopy. Prog. Nucl. Magn. Reson. Spectrosc. 55, 238–265 (2009).

    Google Scholar 

  46. Zhou, J., Payen, J.-F., Wilson, D. A., Traystman, R. J. & van Zijl, P. C. M. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 9, 1085–1090 (2003).

    Google Scholar 

  47. Souza, T. K. F. et al. Image and motor behavior for monitoring tumor growth in C6 glioma model. PLoS One 13, e0201453 (2018).

    Google Scholar 

  48. da Silva, A. C. G. et al. Tumor growth analysis by magnetic resonance imaging of the C6 glioblastoma model with prospects for the assessment of magnetohyperthermia therapy. Einstein 10, 11–15 (2012).

    Google Scholar 

  49. Case, K. C., Schmidtke, M. W. & Greenberg, M. L. The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor. Cancer Metastasis Rev. 41, 249–254 (2022).

    Google Scholar 

  50. Trock, B. J. Application of metabolomics to prostate cancer. Urol. Oncol. Semin. Orig. Investig. 29, 572–581 (2011).

    Google Scholar 

  51. Jordan, K. W. & Cheng, L. L. NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Rev. Proteom. 4, 389–400 (2014).

    Google Scholar 

  52. Knörnschild, F. et al. Correlations of blood and brain NMR metabolomics with Alzheimer’s disease mouse models. Transl. Psychiatry 15, 87 (2025).

  53. Li, Y. et al. T1 and T2 metabolite relaxation times in normal brain at 3T and 7T. J. Mol. Imag. Dyn. 2, 1–6 (2013).

  54. Nanga, R. P. R. et al. Identification of l-Tryptophan by down-field 1H MRS: a precursor for brain NAD+ and serotonin syntheses. Magn. Reson. Med. 88, 2371–2377 (2022).

    Google Scholar 

  55. Wang J. et al. Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS. Metabolomics 12, 116 (2016).

  56. Zhou, Z. et al. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat. Commun. 13, 6656 (2022).

    Google Scholar 

  57. Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis. Metabolomics 3, 211–221 (2007).

    Google Scholar 

  58. Wishart, D. S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35, D521–D526 (2007).

    Google Scholar 

  59. Wiklund, S. et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115–122 (2008).

    Google Scholar 

  60. Trygg, J. & Wold, S. Orthogonal projections to latent structures (O-PLS). J. Chemometrics 16, 119–128 (2002).

    Google Scholar 

  61. Dreher, W. & Leibfritz, D. New method for the simultaneous detection of metabolites and water in localized in vivo 1H nuclear magnetic resonance spectroscopy. Magn. Reson. Med. 54, 190–195 (2005).

    Google Scholar 

  62. Provencher, S. W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14, 260–264 (2001).

    Google Scholar 

  63. Soher, B. J. et al. Vespa: Integrated applications for RF pulse design, spectral simulation and MRS data analysis. Magn. Reson. Med. 90, 823–838 (2023).

    Google Scholar 

  64. Waxmann, P. et al. A new sequence for shaped voxel spectroscopy in the human brain using 2D spatially selective excitation and parallel transmission. NMR Biomed. 29, 1028–1037 (2016).

    Google Scholar 

  65. Özdemir İ., Etyemez S. & Barker P. B. High-field downfield MR spectroscopic imaging in the human brain. Magn. Reson. Med. 92, 890–899 (2024).

Download references